BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26519782)

  • 21. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus screening and cervical cancer prevention.
    Sasieni PD
    J Am Med Womens Assoc (1972); 2000; 55(4):216-9. PubMed ID: 10935355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refining the management of low-grade cervical abnormalities in the UK National Health Service and defining the potential for human papillomavirus testing: a commentary on emerging evidence.
    Bentley E; Cotton SC; Cruickshank ME; Duncan I; Gray NM; Jenkins D; Little J; Neal K; Philips Z; Russell I; Seth R; Sharp L; Waugh N;
    J Low Genit Tract Dis; 2006 Jan; 10(1):26-38. PubMed ID: 16378029
    [No Abstract]   [Full Text] [Related]  

  • 25. Practice Bulletin No. 157 Summary: Cervical Cancer Screening and Prevention.
    Obstet Gynecol; 2016 Jan; 127(1):185-187. PubMed ID: 26695578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management.
    Obstet Gynecol; 2010 Aug; 116(2 Pt 1):469-472. PubMed ID: 20664421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current recommendations for cervical cancer screening: do they render the annual pelvic examination obsolete?
    Kauffman RP; Griffin SJ; Lund JD; Tullar PE
    Med Princ Pract; 2013; 22(4):313-22. PubMed ID: 23328247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.
    Obstet Gynecol; 2016 Jan; 127(1):e1-e20. PubMed ID: 26695583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.
    Jach R; Mazurec M; Trzeszcz M; Zimmer M; Kedzia W; Wolski H
    Ginekol Pol; 2021; 92(2):165-173. PubMed ID: 33751524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification of HPV-positive women in routine cervical screening.
    Cruickshank M
    BJOG; 2021 Jul; 128(8):1363. PubMed ID: 33683821
    [No Abstract]   [Full Text] [Related]  

  • 31. ASCCP Management Guidelines for Abnormal Cervical Cancer Screening.
    Espinosa K
    Am Fam Physician; 2024 Mar; 109(3):275-276. PubMed ID: 38574222
    [No Abstract]   [Full Text] [Related]  

  • 32. Cervical cancer screening guidelines: An update.
    Shami S; Coombs J
    JAAPA; 2021 Sep; 34(9):21-24. PubMed ID: 34448772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical Cancer Screening in Immunocompromised Women.
    McClymont E; Lee M; Elwood C; Mitchell-Foster S; van Schalkwyk J; Ogilvie G; Money D
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1177-1180. PubMed ID: 31235371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.
    Cheung LC; Egemen D; Chen X; Katki HA; Demarco M; Wiser AL; Perkins RB; Guido RS; Wentzensen N; Schiffman M
    J Low Genit Tract Dis; 2020 Apr; 24(2):90-101. PubMed ID: 32243306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical Cancer Screening in Canada.
    Popadiuk C
    J Obstet Gynaecol Can; 2019 Dec; 41 Suppl 2():S177-S180. PubMed ID: 31785651
    [No Abstract]   [Full Text] [Related]  

  • 36. Cervical cancer in South Carolina: problems & solutions through research, practice, and innovation.
    Brandt H; Glover S
    J S C Med Assoc; 2009 Dec; 105(7):225. PubMed ID: 20108705
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk estimation for the next generation of prevention programmes for cervical cancer.
    Katki HA; Wacholder S; Solomon D; Castle PE; Schiffman M
    Lancet Oncol; 2009 Nov; 10(11):1022-3. PubMed ID: 19767237
    [No Abstract]   [Full Text] [Related]  

  • 38. An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
    Schiffman M; Wentzensen N; Perkins RB; Guido RS
    J Low Genit Tract Dis; 2020 Apr; 24(2):87-89. PubMed ID: 32243305
    [No Abstract]   [Full Text] [Related]  

  • 39. Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.
    Wentzensen N; Garcia F; Clarke MA; Massad LS; Cheung LC; Egemen D; Guido R; Huh W; Saslow D; Smith RA; Unger ER; Perkins RB;
    J Low Genit Tract Dis; 2024 Apr; 28(2):117-123. PubMed ID: 38446573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nobel laureate Harald zur Hausen passed. He was the first to discover the HPV-cervical cancer link.
    Bifulco M
    J Med Virol; 2023 Aug; 95(8):e28982. PubMed ID: 37503667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.